Universitat de Barcelona (UB) / University of Barcelona

University / College


Location: Barcelona, Spain (ES) ES

ISNI: 0000000419370247

ROR: https://ror.org/021018s57

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Matched-paired analysis of patients treated for invasive mucormycosis: Standard treatment versus posaconazole new formulations (MoveOn) (2019) Salmanton-Garcia J, Seidel D, Koehler P, Mellinghoff SC, Herbrecht R, Klimko N, Racil Z, et al. Journal article ARIA guideline 2019: treatment of allergic rhinitis in the German health system (2019) Klimek L, Bachert C, Pfaar O, Becker S, Bieber T, Brehler R, Buhl R, et al. Journal article Elemental systematics of the calcitic skeleton of Corallium rubrum and implications for the Mg/Ca temperature proxy (2019) Chaabane S, López Correa M, Ziveri P, Trotter J, Kallel N, Douville E, McCulloch M, et al. Journal article Foreword to the special section on the Eurographics Workshop on Visual Computing for Biology and Medicine (VCBM) at Medical Image Computing and Computer Assisted Intervention (MICCAI) 2018 (2019) Schultz T, Puig A, Kainz B Journal article Time to Flare in Patients with New-Onset versus Relapsing Giant Cell Arteritis Treated with Tocilizumab or Placebo Plus Prednisone Tapering: 3-Year Results from a Randomized Controlled Phase 3 Trial (2019) Stone J, Spotswood H, Unizony S, Aringer M, Blockmans D, Brouwer E, Cid MC, et al. Conference contribution Long-Term Outcome of Tocilizumab for Patients with Giant Cell Arteritis: Results from Part 2 of a Randomized Controlled Phase 3 Trial (2019) Stone J, Bao M, Han J, Aringer M, Blockmans D, Brouwer E, Cid MC, et al. Conference contribution Maintained Benefit in Health-Related Quality of Life of Patients with Giant Cell Arteritis Treated with Tocilizumab Plus Prednisone Tapering: Results from the Open-Label, Long-Term Extension of a Phase 3 Randomized Controlled Trial (2019) Stone J, Han J, Unizony S, Aringer M, Blockmans D, Brouwer E, Cid MC, et al. Conference contribution Delineating the clinical spectrum due to heterozygous TRAF7 missense mutations: A series of 38 cases (2019) Amiel J, Mishra K, Castilla L, Selmer KK, Barak T, Yang S, Blanco-Sanchez B, et al. Conference contribution Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data (2019) Johnston C, Burns R, McNeil J, Tress BM, Campbell BC, Williams M, Ma H, et al. Journal article OBETICHOLIC ACID TREATMENT IS ASSOCIATED WITH IMPROVED COLLAGEN MORPHOMETRY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (2019) Kremer A, Bowlus CL, Bedossa P, Pares A, Forman LM, Drenth JPH, Ryder S, et al. Conference contribution